All insights
Regulatory·5 min read·

FDA Grants Breakthrough Device Designation to Viz.ai Stroke Detection Platform

Viz.ai's AI-powered stroke detection system receives FDA Breakthrough Device Designation, accelerating pathway to expanded stroke triage capabilities. Platform already deployed in 1,500+ hospitals.

World Health AI Summit

<div class="space-y-8"> <div class="bg-gradient-to-br from-purple-900/20 to-indigo-900/20 rounded-2xl p-8 border border-purple-700/30"> <h2 class="text-2xl font-bold text-white mb-4">Regulatory Milestone</h2> <p class="text-gray-100 text-lg leading-relaxed"> Viz.ai received <strong class="text-white">FDA Breakthrough Device Designation</strong> for its expanded AI stroke detection and triage platform, marking a significant regulatory milestone that could accelerate review timelines by <strong class="text-white">6-12 months</strong>. </p> </div> <div class="my-12"> <h2 class="text-3xl font-bold text-white mb-6 pb-4 border-b border-gray-800">Platform Capabilities</h2> <div class="space-y-4"> <div class="bg-gradient-to-r from-blue-900/20 to-cyan-900/20 rounded-lg p-5 border-l-4 border-blue-500"> <h4 class="text-lg font-bold text-white mb-2">Large Vessel Occlusion Detection</h4> <p class="text-gray-300">Real-time detection of LVO in CT angiography</p> </div> <div class="bg-gradient-to-r from-purple-900/20 to-pink-900/20 rounded-lg p-5 border-l-4 border-purple-500"> <h4 class="text-lg font-bold text-white mb-2">Automated ASPECTS Scoring</h4> <p class="text-gray-300">AI-powered stroke severity assessment</p> </div> <div class="bg-gradient-to-r from-green-900/20 to-emerald-900/20 rounded-lg p-5 border-l-4 border-green-500"> <h4 class="text-lg font-bold text-white mb-2">Direct Notification</h4> <p class="text-gray-300">Stroke team alerted within minutes of scan completion</p> </div> <div class="bg-gradient-to-r from-orange-900/20 to-red-900/20 rounded-lg p-5 border-l-4 border-orange-500"> <h4 class="text-lg font-bold text-white mb-2">Mobile Integration</h4> <p class="text-gray-300">Seamless workflow with mobile stroke units</p> </div> </div> </div> <div class="grid grid-cols-1 md:grid-cols-2 gap-6 my-10"> <div class="bg-gray-900/50 rounded-xl p-6 border border-gray-700"> <h4 class="text-sm font-semibold text-gray-400 uppercase tracking-wide mb-3">Time Savings</h4> <div class="text-3xl font-bold text-green-400 mb-1">43 min</div> <p class="text-sm text-gray-400">Avg reduction in door-to-treatment</p> </div> <div class="bg-gray-900/50 rounded-xl p-6 border border-gray-700"> <h4 class="text-sm font-semibold text-gray-400 uppercase tracking-wide mb-3">Detection Accuracy</h4> <div class="text-3xl font-bold text-blue-400 mb-1">96%</div> <p class="text-sm text-gray-400">Sensitivity for LVO detection</p> </div> <div class="bg-gray-900/50 rounded-xl p-6 border border-gray-700"> <h4 class="text-sm font-semibold text-gray-400 uppercase tracking-wide mb-3">Hospital Deployment</h4> <div class="text-3xl font-bold text-purple-400 mb-1">1,500+</div> <p class="text-sm text-gray-400">Facilities across 45 countries</p> </div> <div class="bg-gray-900/50 rounded-xl p-6 border border-gray-700"> <h4 class="text-sm font-semibold text-gray-400 uppercase tracking-wide mb-3">Outcome Improvement</h4> <div class="text-3xl font-bold text-orange-400 mb-1">21%</div> <p class="text-sm text-gray-400">Better functional independence at 90 days</p> </div> </div> <div class="bg-gradient-to-br from-orange-900/30 to-red-900/30 rounded-2xl p-8 border border-orange-700/50 my-12"> <h3 class="text-2xl font-bold text-white mb-4">Market Implications</h3> <p class="text-gray-100 text-lg leading-relaxed"> This designation strengthens Viz.ai's position in the <strong class="text-white">$400M acute care AI market</strong> and follows similar regulatory wins for competitors IDx-DR (diabetic retinopathy) and Caption Health (ultrasound guidance). </p> </div> <div class="border-t border-gray-800 pt-6"> <p class="text-sm text-gray-500 italic"> <strong>Source:</strong> FDA Medical Devices Database, Viz.ai, Journal of Neurointerventional Surgery </p> </div> </div>

This briefing summarises publicly available research and reporting for information only. It is not medical, investment, or legal advice. Follow the references above to the primary sources.